Healthcare - Biotechnology - NASDAQ - US
$ 0.0001
0 %
$ 3.07 K
Market Cap
0.0
P/E
CASH FLOW STATEMENT
-9.77 M
OPERATING CASH FLOW
-28.6 K
INVESTING CASH FLOW
5.24 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Comera Life Sciences Holdings, Inc.
| Net Income | -18 M |
| Depreciation & Amortization | 93.9 K |
| Capital Expenditures | -28.6 K |
| Stock-Based Compensation | 376 K |
| Change in Working Capital | 2.55 M |
| Others | 6.93 M |
| Free Cash Flow | -9.8 M |
Cash Flow
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|
| OPERATING CASH FLOW | |||
| Net Income | (18.0) | (5.5) | (2.1) |
| Depreciation & Amortization | 93.9 K | 86.1 K | 89.7 K |
| Deferred Income Tax | 0 | (0.2) | 1.39 K |
| Stock Based Compensation | 0.4 | 1.1 | 0.1 |
| Other Operating Activities | 5.2 | 79.4 K | 0.2 |
| Change in Working Capital | 2.6 | 0.6 | 41.9 K |
| Cash From Operations | (9.8) | (3.8) | (1.8) |
| INVESTING CASH FLOW | |||
| Capital Expenditures | 28.6 K | (0.1) | 12.4 K |
| Other Items | 0 | 0 | 0 |
| Cash From Investing Activities | 28.6 K | (0.1) | 12.4 K |
| FINANCING CASH FLOW | |||
| Common Stock Repurchased | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0.8 | 0.2 |
| Dividends Paid | 0 | 0 | 0 |
| Other Financing Activities | 4.4 | 9.5 | 0 |
| Cash From Financing Activities | 5.2 | 10.3 | 1.6 |
| CHANGE IN CASH | |||
| Net Change In Cash | (4.6) | 6.4 | (0.3) |
| FREE CASH FLOW | |||
| Free Cash Flow | (9.8) | (3.9) | (1.8) |